BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24024139)

  • 1. Differential activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy.
    Khoo NK; Hebbar S; Zhao W; Moore SA; Domann FE; Robbins ME
    Redox Biol; 2013; 1(1):70-9. PubMed ID: 24024139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes.
    Dello Russo C; Gavrilyuk V; Weinberg G; Almeida A; Bolanos JP; Palmer J; Pelligrino D; Galea E; Feinstein DL
    J Biol Chem; 2003 Feb; 278(8):5828-36. PubMed ID: 12486128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma.
    Pérez-Ortiz JM; Tranque P; Vaquero CF; Domingo B; Molina F; Calvo S; Jordán J; Ceña V; Llopis J
    J Biol Chem; 2004 Mar; 279(10):8976-85. PubMed ID: 14699130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.
    Girnun GD; Domann FE; Moore SA; Robbins ME
    Mol Endocrinol; 2002 Dec; 16(12):2793-801. PubMed ID: 12456800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
    Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
    J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY; Cho IJ; Kim SG
    Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
    Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
    J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice.
    Jesse CR; Bortolatto CF; Wilhelm EA; Roman SS; Prigol M; Nogueira CW
    J Appl Toxicol; 2014 Jan; 34(1):25-32. PubMed ID: 22987311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
    J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes.
    Teruel T; Hernandez R; Benito M; Lorenzo M
    J Biol Chem; 2003 Jan; 278(1):263-9. PubMed ID: 12414803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naïve, untreated cells and enhancement in LPS-stimulated cells.
    Sergeeva MG; Aleshin SE; Grabeklis S; Reiser G
    J Neurochem; 2010 Oct; 115(2):399-410. PubMed ID: 20670373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and anti-oxidant mechanisms of an MMP-8 inhibitor in lipoteichoic acid-stimulated rat primary astrocytes: involvement of NF-κB, Nrf2, and PPAR-γ signaling pathways.
    Lee EJ; Park JS; Lee YY; Kim DY; Kang JL; Kim HS
    J Neuroinflammation; 2018 Nov; 15(1):326. PubMed ID: 30470240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice.
    Barbieri M; Di Filippo C; Esposito A; Marfella R; Rizzo MR; D'Amico M; Ferraraccio F; Di Ronza C; Duan SZ; Mortensen RM; Rossi F; Paolisso G
    PLoS One; 2012; 7(4):e35999. PubMed ID: 22563432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.
    Raso GM; Esposito E; Vitiello S; Iacono A; Santoro A; D'Agostino G; Sasso O; Russo R; Piazza PV; Calignano A; Meli R
    J Neuroendocrinol; 2011 Jul; 23(7):591-600. PubMed ID: 21554431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts.
    Spagnolo A; Glick RP; Lin H; Cohen EP; Feinstein DL; Lichtor T
    J Neurosurg; 2007 Feb; 106(2):299-305. PubMed ID: 17410715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse.
    Okuno Y; Matsuda M; Miyata Y; Fukuhara A; Komuro R; Shimabukuro M; Shimomura I
    Endocr J; 2010; 57(4):303-9. PubMed ID: 20075562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma.
    Kawashima A; Harada T; Imada K; Yano T; Mizuguchi K
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):59-65. PubMed ID: 18762411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.